LT3743086T - Kompozicijos, apimančios bakterinius kamienus - Google Patents

Kompozicijos, apimančios bakterinius kamienus

Info

Publication number
LT3743086T
LT3743086T LTEPPCT/EP2019/062238T LTEP2019062238T LT3743086T LT 3743086 T LT3743086 T LT 3743086T LT EP2019062238 T LTEP2019062238 T LT EP2019062238T LT 3743086 T LT3743086 T LT 3743086T
Authority
LT
Lithuania
Prior art keywords
bacterial strains
compositions including
including bacterial
compositions
strains
Prior art date
Application number
LTEPPCT/EP2019/062238T
Other languages
English (en)
Inventor
Imke Elisabeth MULDER
Parthena FOTIADOU
Amy Beth HOLT
Suaad AHMED
Anna ETTORRE
Samantha YUILLE
Ted DINAN
John CRYAN
Original Assignee
4D Pharma Research Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1810386.1A external-priority patent/GB201810386D0/en
Priority claimed from GBGB1813460.1A external-priority patent/GB201813460D0/en
Priority claimed from GBGB1817642.0A external-priority patent/GB201817642D0/en
Priority claimed from GBGB1820256.4A external-priority patent/GB201820256D0/en
Priority claimed from GBGB1820264.8A external-priority patent/GB201820264D0/en
Application filed by 4D Pharma Research Limited filed Critical 4D Pharma Research Limited
Publication of LT3743086T publication Critical patent/LT3743086T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pediatric Medicine (AREA)
  • Transplantation (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
LTEPPCT/EP2019/062238T 2018-05-11 2019-05-13 Kompozicijos, apimančios bakterinius kamienus LT3743086T (lt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP18171893 2018-05-11
EP18178136 2018-06-15
GBGB1810386.1A GB201810386D0 (en) 2018-06-25 2018-06-25 Compositions comprising bacterial strains
GBGB1813460.1A GB201813460D0 (en) 2018-08-17 2018-08-17 Compositions comprising bacterial strains
GBGB1817642.0A GB201817642D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GBGB1820256.4A GB201820256D0 (en) 2018-12-12 2018-12-12 Compositions comprising bacterial strains
GBGB1820264.8A GB201820264D0 (en) 2018-12-12 2018-12-12 Compositions comprising bacterial strains
PCT/EP2019/062238 WO2019215346A1 (en) 2018-05-11 2019-05-13 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
LT3743086T true LT3743086T (lt) 2022-06-10

Family

ID=66597549

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2019/062238T LT3743086T (lt) 2018-05-11 2019-05-13 Kompozicijos, apimančios bakterinius kamienus

Country Status (23)

Country Link
US (3) US11419902B2 (lt)
EP (4) EP4066845A1 (lt)
JP (3) JP7058449B2 (lt)
KR (2) KR20210008391A (lt)
CN (2) CN112512539A (lt)
AU (3) AU2019267170A1 (lt)
BR (1) BR112020022833A2 (lt)
CA (2) CA3098971A1 (lt)
CY (1) CY1125211T1 (lt)
DK (1) DK3743086T3 (lt)
ES (1) ES2916601T3 (lt)
HR (1) HRP20220578T1 (lt)
IL (1) IL278471B2 (lt)
LT (1) LT3743086T (lt)
MD (1) MD3743086T2 (lt)
MX (1) MX2020012061A (lt)
PL (1) PL3743086T3 (lt)
RS (1) RS63273B1 (lt)
SG (2) SG11202011031UA (lt)
SI (1) SI3743086T1 (lt)
SM (1) SMT202200217T1 (lt)
TW (2) TW202014513A (lt)
WO (2) WO2019215346A1 (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2986558T3 (es) 2017-01-31 2024-11-11 Univ Kansas State Células microbianas, métodos de producción de las mismas y usos de las mismas
MA49010B1 (fr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
UY37944A (es) 2017-10-20 2019-05-31 Ms Biotech Inc Métodos para producir materiales vegetales ensilados usando megasphaera elsdenii
SG11202011031UA (en) * 2018-05-11 2020-12-30 4D Pharma Res Ltd Compositions comprising bacterial strains
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020120714A1 (en) * 2018-12-12 2020-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
EP3893906A1 (en) * 2018-12-12 2021-10-20 4D Pharma Research Limited Compositions comprising bacterial strains
WO2021252861A1 (en) * 2020-06-11 2021-12-16 Evelo Biosciences, Inc. Compositions and methods for treating diseases and disorders using megasphaera sp
CN112980878B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac8基因敲除的bhk-21细胞系及其构建方法和应用
CN112877275B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
US20250332201A1 (en) 2022-04-28 2025-10-30 Moon (guangzhou) Biotech Co., Ltd. Pharmaceutical composition, megasphaera, and use thereof
US20250288619A1 (en) 2022-04-28 2025-09-18 Moon (guangzhou) Biotech Co., Ltd. Pharmaceutical composition, megasphaera, and use thereof
KR102551061B1 (ko) * 2022-05-26 2023-07-03 중앙대학교 산학협력단 Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물
CN117018036B (zh) * 2023-07-28 2025-09-05 深圳未知君生物科技有限公司 巨球形菌属细菌在制备治疗癌症的药物中的应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557520A (en) * 1978-10-26 1980-04-28 Nisshin Flour Milling Co Ltd Preparation of carcinostatic substance
WO2002080947A1 (fr) 2001-04-06 2002-10-17 Kyodoken Institute For Animal Science Research & Development Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20040005304A1 (en) 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
GB0307026D0 (en) * 2003-03-27 2003-04-30 Rowett Res Inst Bacterial supplement
CA2535889A1 (en) 2003-08-29 2005-03-17 Aton Pharma, Inc. Combination methods of treating cancer
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
DK3628161T3 (da) 2012-11-23 2023-05-30 Seres Therapeutics Inc Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3021853A1 (en) * 2013-07-18 2016-05-25 Baylor College Of Medicine Method of enhancing potency of immune cells
CN104415060A (zh) * 2013-08-30 2015-03-18 深圳华大基因科技有限公司 可食用组合物及其制备方法和用途
US10203329B2 (en) * 2013-09-12 2019-02-12 The Johns Hopkins University Biofilm formation to define risk for colon cancer
KR102611070B1 (ko) 2013-11-25 2023-12-07 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9650654B2 (en) * 2014-06-25 2017-05-16 William Marsh Rice University Making C4+ products in bacteria
US10366793B2 (en) * 2014-10-21 2019-07-30 uBiome, Inc. Method and system for characterizing microorganism-related conditions
EP3215139B1 (en) * 2014-11-03 2020-08-19 Cerus Corporation Compositions and methods for improved car-t cell therapies
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR102735818B1 (ko) * 2015-01-23 2024-11-28 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 암 예방에서 단쇄 지방산의 용도
WO2016149449A1 (en) 2015-03-18 2016-09-22 Tufts University Compositions and methods for preventing colorectal cancer
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2017085520A1 (en) * 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains
ES2938361T3 (es) * 2015-11-24 2023-04-10 Seres Therapeutics Inc Composiciones de bacterias diseñadas
CN108779434A (zh) * 2016-01-11 2018-11-09 3Plw有限责任公司 被遗传修饰以分泌多糖降解酶的利用乳酸的细菌
CN107028985A (zh) * 2016-02-04 2017-08-11 深圳华大基因研究院 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用
US20190125808A1 (en) * 2016-03-30 2019-05-02 The Trustees Of Columbia University In The City Of New York Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria
US9999641B2 (en) * 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
BR112019006041A2 (pt) * 2016-09-27 2019-09-03 Board Of Regents, The University Of Texas System métodos para aprimorar a terapia de bloqueio do ponto de verificação imunológico por modulação do microbioma
WO2018094190A2 (en) 2016-11-18 2018-05-24 Sanford Burnham Prebys Medical Discovery Institute Gut microbiota and treatment of cancer
WO2018112365A2 (en) 2016-12-16 2018-06-21 Evelo Biosciences, Inc. Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
US20190314427A1 (en) 2016-12-16 2019-10-17 Evelo Biosciences, Inc. Methods of treating cancer using parabacteroides
MA49010B1 (fr) * 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
LT3600363T (lt) * 2017-06-14 2021-02-10 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
SG11202011031UA (en) * 2018-05-11 2020-12-30 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2020120714A1 (en) * 2018-12-12 2020-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
EP3893906A1 (en) * 2018-12-12 2021-10-20 4D Pharma Research Limited Compositions comprising bacterial strains

Also Published As

Publication number Publication date
JP7058449B2 (ja) 2022-04-22
AU2019267170A1 (en) 2021-01-07
JP2022088631A (ja) 2022-06-14
EP4056192A1 (en) 2022-09-14
AU2019267171A1 (en) 2021-01-07
SMT202200217T1 (it) 2022-07-21
SG11202011031UA (en) 2020-12-30
WO2019215345A1 (en) 2019-11-14
SG11202011028SA (en) 2020-12-30
DK3743086T3 (da) 2022-05-02
JP2021523895A (ja) 2021-09-09
US20210052671A1 (en) 2021-02-25
MD3743086T2 (ro) 2022-12-31
KR20210008391A (ko) 2021-01-21
IL278471B1 (en) 2023-04-01
US20210275605A1 (en) 2021-09-09
RS63273B1 (sr) 2022-06-30
HRP20220578T1 (hr) 2022-09-16
KR20210008393A (ko) 2021-01-21
IL278471B2 (en) 2023-08-01
US20230158083A1 (en) 2023-05-25
CN112601534A (zh) 2021-04-02
IL278471A (lt) 2020-12-31
CA3098971A1 (en) 2019-11-14
EP3743086B1 (en) 2022-03-16
SI3743086T1 (sl) 2022-05-31
TW202011975A (zh) 2020-04-01
PL3743086T3 (pl) 2022-06-20
WO2019215346A1 (en) 2019-11-14
CA3099209A1 (en) 2019-11-14
EP4066845A1 (en) 2022-10-05
CY1125211T1 (el) 2024-02-16
EP3790564A1 (en) 2021-03-17
BR112020022833A2 (pt) 2021-02-02
AU2023200562A1 (en) 2023-03-02
MX2020012061A (es) 2022-10-13
EP3743086A1 (en) 2020-12-02
CN112512539A (zh) 2021-03-16
TW202014513A (zh) 2020-04-16
ES2916601T3 (es) 2022-07-04
JP2021517560A (ja) 2021-07-26
US11419902B2 (en) 2022-08-23

Similar Documents

Publication Publication Date Title
LT3743086T (lt) Kompozicijos, apimančios bakterinius kamienus
DK3804737T3 (da) Sammensætninger omfattende bakteriestammer
LT3307288T (lt) Kompozicijos, apimančios bakterijų kamienus
LT3206700T (lt) Kompozicijos, apimančios bakterijų kamienus
DK3377082T3 (da) Sammensætninger, der omfatter bakteriestammer
MA40754A (fr) Compositions comprenant des souches bactériennes
MA41708A (fr) Compositions comprenant des souches bactériennes
LT3549592T (lt) Kompozicijos, apimančios bakterijų kamienus
DK3630136T3 (da) Sammensætninger, der omfatter bakteriestammer
DK3600363T3 (da) Sammensætninger omfattende bakteriestammer
LT3638271T (lt) Kompozicijos, apimančios bakterines padermes
MA52128A (fr) Compositions comprenant des souches bactériennes
MA49982A (fr) Compositions comprenant des souches bactériennes
MA53155A (fr) Compositions comprenant des souches bactériennes
MA53860A (fr) Compositions comprenant des souches bactériennes
MA53228A (fr) Compositions comprenant des souches bactériennes
LT3723777T (lt) Kompozicijos, apimančios bakterines padermes
EP3998852A4 (en) Novel bacterial strains
MA54074A (fr) Compositions comprenant des souches bactériennes
MA51709A (fr) Compositions comprenant des souches bactériennes
GB201820744D0 (en) Compositions comprising bacterial strains
GB201820261D0 (en) Compositions comprising bacterial strains
GB201820264D0 (en) Compositions comprising bacterial strains
MA49322A (fr) Compositions comprenant des souches bactériennes
GB201817642D0 (en) Compositions comprising bacterial strains